With public health authorities increasingly vigilant about another influenza pandemic, the European Commission and 15 EU member states have signed contracts with Seqirus UK Ltd for the supply of influenza vaccines that might be used in an emergency. Announcing the deal on 8 April, the company said the pandemic contracts are the first to be executed under a new EU joint procurement framework. Financial terms were not disclosed.
